These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 6280269)

  • 1. Cefotaxime therapy of serious infections with multiresistant gram-negative bacilli.
    Clumeck N; van Laethem Y; Vanhoof R; George C; Rapin M; Butzler JP
    Scand J Infect Dis; 1982; 14(1):57-60. PubMed ID: 6280269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Cefotaxime in the treatment of severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Clumeck N; Van Laethem Y; Vanhoof R; Jaspar N; George G; Rapin M; Butzler JP
    Nouv Presse Med; 1981 Feb; 10(8):622-4. PubMed ID: 6259606
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Cefotaxime in septicaemia and severe infections due to multiresistant Gram-negative bacilli (author's transl)].
    Dureux JB; Canton P; Roche G; Weber M; Gérard A
    Nouv Presse Med; 1981 Feb; 10(8):601-6. PubMed ID: 6259602
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Summary of comparative clinical studies of ceftizoxime and cefamandole, cefazolin and tobramycin.
    Duma RJ
    J Antimicrob Chemother; 1982 Nov; 10 Suppl C():303-9. PubMed ID: 6296025
    [No Abstract]   [Full Text] [Related]  

  • 5. Ceftriaxone therapy of serious bacterial infections in adults.
    Bittner MJ; Dworzack DL; Preheim LC; Tofte RW; Crossley KB
    Antimicrob Agents Chemother; 1983 Feb; 23(2):261-6. PubMed ID: 6301365
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cefotaxime compared with nafcillin plus tobramycin for serious bacterial infections. A randomized, double-blind trial.
    Smith CR; Ambinder R; Lipsky JJ; Petty BG; Israel E; Levitt R; Mellits ED; Rocco L; Longstreth J; Lietman PS
    Ann Intern Med; 1984 Oct; 101(4):469-77. PubMed ID: 6089633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cefotaxime: efficacy and tolerance in lower respiratory tract infections caused by gram-positive cocci.
    Lode H; Glatzel PD
    Infection; 1985; 13 Suppl 1():S25-7. PubMed ID: 4055050
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of ampicillin/sulbactam versus cefotaxime in the therapy of lower respiratory tract infections in hospitalized patients.
    Jauregui L; Minns P; Hageage G
    J Chemother; 1995 Apr; 7(2):153-6. PubMed ID: 7666123
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cefotaxime in urinary tract infections.
    Naber KG
    Infection; 1989; 17(6):425-8. PubMed ID: 2693361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cefotaxime is more effective than is ampicillin-tobramycin in cirrhotics with severe infections.
    Felisart J; Rimola A; Arroyo V; Perez-Ayuso RM; Quintero E; Gines P; Rodes J
    Hepatology; 1985; 5(3):457-62. PubMed ID: 3888810
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cefotaxime (HR-756) in urinary tract infections.
    Paradisi F; Cristiano P; Mirone V; D'Armiento V; Iovene MR
    Chemotherapy; 1982; 28(1):64-9. PubMed ID: 6276110
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Effect of cefotaxime in the treatment of infections associated with hematologic diseases].
    Kaneko H; Masaki T; Yamaguchi R; Takahashi N; Umeda M; Shirai T
    Jpn J Antibiot; 1983 Sep; 36(9):2502-14. PubMed ID: 6317914
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ceftizoxime vs. cefotaxime--a comparative randomized multicenter study.
    Segev S; Kitzes R; Rubinstein E; Pitlik S; Samra Y; Shenkman L; Weinberg M
    Isr J Med Sci; 1988 Aug; 24(8):410-4. PubMed ID: 3045049
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative clinical study of tobramycin and gentamicin.
    Klastersky J; Hensgens C; Henri A; Daneau D
    Antimicrob Agents Chemother; 1974 Feb; 5(2):133-8. PubMed ID: 4599859
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Use of aztreonam in the treatment of serious infections due to multiresistant gram-negative organisms, including Pseudomonas aeruginosa.
    Scully BE; Neu HC
    Am J Med; 1985 Feb; 78(2):251-61. PubMed ID: 4038574
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ceftriaxone in the treatment of serious infections, particularly after surgery.
    Scully BE; Neu HC
    Am J Surg; 1984 Oct; 148(4A):35-40. PubMed ID: 6091479
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cefotaxime in the treatment of lower respiratory tract infections.
    Beumer HM; Veldkamp J; Deleers L
    Int J Clin Pharmacol Ther Toxicol; 1983 Dec; 21(12):605-10. PubMed ID: 6321367
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of tobramycin and gentamicin].
    Klastersky J; Daneau D; Henri A
    Acta Clin Belg; 1972; 27(5):589-99. PubMed ID: 4205788
    [No Abstract]   [Full Text] [Related]  

  • 19. Ampicillin/sulbactam compared with cefotaxime in the treatment of lower respiratory tract infections of bacterial etiology.
    Jauregui L; Minns P; Hageage G
    Adv Ther; 1995; 12(1):62-71. PubMed ID: 10150322
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of cefotaxime, a beta-lactamase stable cephalosporin, in the therapy of serious infections, including those due to multiresistant organisms.
    Francke EL; Neu HC
    Am J Med; 1981 Sep; 71(3):435-42. PubMed ID: 6269426
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.